X
XFOR
X4 Pharmaceuticals Inc
4.100
+0.030+0.74%After Hours: 4.100 0.000 0.00%17:36 04/10 EDT
OPEN/PREV CLOSE4.060/4.070
TODAY RANGE3.990-4.126
VOL235.12K
MARKET CAP372.77M
52 WEEK RANGE1.350-6.96
AVG VOL (3M)482.82K
% TURNOVER0.26%
TURNOVER--
P/E (TTM)-2.1895
% RANGE3.10%
EPS(TTM)-1.8726
P/E(FORWARD)-4.6591
P/B2.001
BVPS2.049
DIVIDEND--
P/S10.61
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP343.79M
SHARES OUTSTANDING90.92M
NEXT EARNINGS04/29-05/04
FREE FLOAT83.85M
LOT SIZE1
EX-DATE04/28/2025
News
Press Releases
Financial Reports
Profile
Seeking Alpha·23h ago
Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings
NASDAQ·03/27 03:14
X4 Pharmaceuticals (XFOR) Price Target Increased by 25.00% to 11.90
Reuters·03/20 12:46
X4 Pharmaceuticals Inc. Announces Annual Stockholders Meeting Notice
Reuters·03/17 20:33
ImageneBio names Bob Lally principal accounting officer as Erin Butler exits
Benzinga·03/17 17:05
12 Health Care Stocks Moving In Tuesday's Intraday Session
NASDAQ·03/17 12:25
X4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue Estimates
Benzinga·03/17 12:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Reuters·03/17 11:29
Rare disease drugmaker X4 Pharma's Q4 revenue rises on XOLREMDI strength
Seeking Alpha·03/17 11:26
X4 Pharmaceuticals GAAP EPS of -$0.22 beats by $0.13, revenue of $2.57M beats by $0.84M
TipRanks·03/17 11:20
X4 Pharmaceuticals reports Q4 EPS (22c), consensus (35c)
TipRanks·03/17 11:20
X4 Pharmaceuticals sees cash runway through 2028
Same Industry